Business Description
Oramed Pharmaceuticals is a drug development company focused on creating pills that deliver proteins and insulin directly through the digestive system, removing the need for injections. Its lead product, an oral insulin capsule, has advanced to late-stage clinical trials for people living with diabetes. The company also holds licensing rights to develop oral COVID-19 vaccines through a partnership with Oravax Medical. Founded in 2002 and based in New York, Oramed aims to make treatment easier and more accessible for patients worldwide.
